To inform clinicians on the best biologic agent for different populations of adults with severe asthma, 12 experts ...

A peer-reviewed study published in Comprehensive Psychiatry found that a single 10-milligram oral dose of psilocybin significantly reduced obsessive-compulsive disorder symptoms in 19 adults, with ...

Initiation of GLP-1 drugs was associated with a 14% lower risk of developing new substance use disorders compared with SGLT2 inhibitors in veterans. Veterans with pre-existing substance use disorders ...

A 2025 study shows that an AI-based tutor improves learning when it prompts reasoning and is paired with peer discussion.

These findings build on the earlier Company-sponsored Phase 1b/2 study, RELEASE, 1 which established the tolerability profile of selected BXCL501 doses in opioid-dependent patients and extend those ...

Changes in federal prescribing recommendations follow deliberate and transparent processes involving US Food and Drug Administration (FDA) scientists, which normally include input from stakeholders ...

Introduction Incidental pulmonary nodules (IPNs) are commonly encountered on chest radiographs (CXRs) performed for routine clinical indications and may represent early manifestations of significant ...

Prothena Corporation plc kept at Hold after mixed phase 2 results; key phase 3 readouts expected 2029. Click for this updated ...

The trials are evaluating DURAVYU (vorolanib intravitreal insert) for the treatment of diabetic macular edema (DME).

The exported NPX-5 product will now be used in Psyence BioMed’s ongoing Phase IIb clinical trial in Australia – a double-blind, randomized, low-dose comparator-controlled, multi-center study ...

More than three years after ChatGPT debuted, AI has become a part of everyday life — and professors and students are still ...

Shares of uniQure plummeted more than 40% in premarket trading Monday after the company confirmed the FDA has rejected its current data package for AMT-130, a highly anticipated gene therapy for ...